Nelangi M. Pinto

ORCID: 0000-0002-6450-916X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Congenital Heart Disease Studies
  • Cardiovascular Issues in Pregnancy
  • Congenital Diaphragmatic Hernia Studies
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments
  • Healthcare Policy and Management
  • Ultrasound in Clinical Applications
  • Aortic Disease and Treatment Approaches
  • Mechanical Circulatory Support Devices
  • Cardiovascular Function and Risk Factors
  • Cardiac, Anesthesia and Surgical Outcomes
  • Heart Failure Treatment and Management
  • Prenatal Screening and Diagnostics
  • Cardiac Arrest and Resuscitation
  • Systemic Lupus Erythematosus Research
  • Transplantation: Methods and Outcomes
  • Congenital heart defects research
  • Palliative Care and End-of-Life Issues
  • Coronary Artery Anomalies
  • Cardiovascular Conditions and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Renal and Vascular Pathologies
  • Ethics and Legal Issues in Pediatric Healthcare
  • Vascular anomalies and interventions

University of Washington
2003-2025

Seattle Children's Hospital
2022-2025

Primary Children's Hospital
2012-2024

University of Utah
2015-2024

University of Washington Medical Center
2024

AID Atlanta
2023

Seattle University
2022

Texas Children's Hospital
2021

Baylor College of Medicine
2021

Society for Maternal-Fetal Medicine
2020

OBJECTIVES. Obesity may pose additional cardiovascular risk to children with acquired and congenital heart disease. Many disease are sedentary as a result of physician-, parent-, and/or self-imposed restrictions. The aim this study was evaluate the impact epidemic obesity on PATIENTS AND METHODS. A cross-sectional review performed evaluated in 2004 at 2 cardiology outpatient clinics. Differences prevalence obese (BMI ≥ 95%) overweight 85%–95%) were compared national data healthy control...

10.1542/peds.2007-0306 article EN PEDIATRICS 2007-11-01

To evaluate the extent and determinants of missed prenatal detection congenital heart disease (CHD) in a population-based setting.This was retrospective cohort study cases with CHD, excluding minor defects, identified between 1997 2007 by statewide surveillance program. We examined comprehensive list potential risk factors for which data were available database from abstracted medical charts. analyzed association fetal, maternal encounter 1) whether ultrasound performed 2) CHD.CHD detected...

10.1002/uog.10116 article EN Ultrasound in Obstetrics and Gynecology 2011-10-13

Prenatal detection (PND) has benefits for infants with hypoplastic left heart syndrome (HLHS) and transposition of the great arteries (TGA), but associations between sociodemographic geographic factors PND have not been sufficiently explored. This study evaluated whether socioeconomic quartile (SEQ), public insurance, race ethnicity, rural residence, distance residence (distance driving time from a cardiac surgical center) are associated or timing PND, secondary aim to analyze differences...

10.1161/circulationaha.120.053062 article EN Circulation 2021-05-17

Newborn screening for critical congenital heart defects (CCHD) was added to the US Recommended Uniform Screening Panel in 2011. Within 4 years, 46 states and District of Columbia had adopted it into their newborn program, leading CCHD being nearly universal United States. This rapid adoption occurred while there were still questions about effectiveness recommended protocol barriers follow-up infants with a positive screen. In response, Centers Disease Control Prevention partnered American...

10.1542/peds.2015-4573 article EN PEDIATRICS 2016-04-15

Objective This prospective study of pregnant patients, S urveillance To P revent AV B lock L ikely to O ccur Q uickly (STOP BLOQ), addresses the impact anti‐SSA/Ro titers and utility ambulatory monitoring in detection fetal second‐degree atrioventricular block (AVB). Methods Women with autoantibodies by commercial testing were stratified into high low anti–52‐kD and/or 60‐kD SSA/Ro applying at‐risk thresholds defined previous evaluation AVB pregnancies. The high‐titer group performed heart...

10.1002/art.42733 article EN Arthritis & Rheumatology 2023-11-10

In 2011, the U.S. Department of Health and Human Services added critical congenital heart disease (CCHD), which occurs in two every 1,000 births, to list conditions recommended states for universal newborn screening (1). Without early detection, infants with CCHD are at risk substantial morbidity death first weeks months life (2). Based on 2007-2013 data, deaths from other cardiac causes aged <6 significantly declined born eight after they had fully implemented mandated policies by June 2013...

10.15585/mmwr.mm6805a3 article EN MMWR Morbidity and Mortality Weekly Report 2019-02-07

The economic implications of strategies to improve prenatal screening for congenital heart disease (CHD) in low-risk mothers have not been explored. aim was perform a cost-effectiveness analysis different methods.We constructed decision analytic model CHD (four-chamber screen (4C), 4C + outflow, nuchal translucency (NT) or fetal echocardiography) populated with probabilities from the literature. included whether initial screens were interpreted by maternal-fetal medicine (MFM) specialist and...

10.1002/uog.13287 article EN Ultrasound in Obstetrics and Gynecology 2013-12-19

ace and ethnicity, socioeconomic status (SES), geography have been associated with differential outcomes in congenital heart disease death.In patients hypoplastic left syndrome (HLHS), lower SES has increased complications 1-year survival. 1o previous study examined how sociodemographics affect neonatal death among prenatally diagnosed HLHS.The goal was to investigate infants a prenatal diagnosis of HLHS understand associations between maternal patient characteristics hospital discharge...

10.1161/circulationaha.123.064476 article EN Circulation 2023-07-17

Fetuses with congenital heart disease (CHD) are at increased risk of pregnancy loss compared the general population. We aimed to assess incidence, timing and factors in cases major fetal CHD, overall according cardiac diagnosis.

10.1002/uog.26231 article EN Ultrasound in Obstetrics and Gynecology 2023-04-26

To describe neurobehavioral patterns in neonates with congenital heart disease (CHD).A cohort study describing performance of CHD requiring cardiac surgery. The were evaluated preoperatively and postoperatively the Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) scores compared published normative values. Clinical factors obtained by chart review to assess their association behavior. NNNS score pattern was previously reported profiles other high-risk populations.NNNS...

10.1111/dmcn.13912 article EN Developmental Medicine & Child Neurology 2018-05-10

Fetal echocardiography is widely available, but normative data are not robust. In this pilot study, the authors evaluated (1) feasibility of prespecified measurements in a normal fetal echocardiogram to inform study design and (2) measurement variability assign thresholds clinical significance guide analyses larger echocardiographic Z score initiatives.Images from predefined gestational age groups (16-20, >20-24, >24-28, >28-32 weeks) were retrospectively analyzed. expert raters attended...

10.1016/j.echo.2023.05.010 article EN cc-by-nc-nd Journal of the American Society of Echocardiography 2023-06-10
Coming Soon ...